Future UK Microbiology Testing Market Outlook

Date: February 10, 2012
Pages: 978
Price:
US$ 5,900.00 US$ 5,015.00
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: UBAFA552C6BEN
Leaflet:

Download PDF Leaflet

Future UK Microbiology Testing Market Outlook
Highlights
  • Comprehensive 978-page analysis of the UK microbiology testing market.
  • Major issues pertaining to the UK microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
  • Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in UK hospitals, blood banks, public health and commercial laboratories.
  • Instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.
Contains 978 pages and 159 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. MAJOR INFECTIOUS DISEASE TESTS


1. AIDS
  a. Background
    Structure and Composition
    Classification
    Origin of AIDS
    Animal Lentivirus Systems
    Virus Receptos
    HIV Infections in Humans
      Pathogenesis & Pathology: Overview of HIV Infection Course
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
      Clinical Findings
    Plasma Viral Load
    Pediatric AIDS
      Neurologic Disease
      Opportunistic Infections
      Cancer
    Immunity
      Virus Isolation
      Serology
      Detection of Viral Nucleic Acid and Antigens
    Infectivity
    Epidemiology
      Worldwide Spread of AIDS
      United States
      Routes of Transmission
  b. Diagnostic Tests
    Laboratory Diagnosis
      Enzyme Immunoassay Interpretation
      Specific, Sensitivity, and Predictive Value of Enzyme Immunoassays
    Competition Assays
    Western Blot Technique
    Immuno-Fluorescence Assay (IFA)
    Radioimmunoprecipitation
    HIV-1/HIV-2 Combination Testing
    Methods of HIV-Antigen Detection
    Antigen Assays and Blood Screening
    Urine Tests
    Immunopathogenic Mechanism of HIV Infection
    DNA Probes
      Overview
      Quantitative Polymerase Chain Reaction
      In Situ PCR
      Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Consideration
  c. Vaccines and Drugs
      Antiviral Drugs
      Vaccines Against HIV
    Transmission of HIV in Blood Products
    HIV Transmission in Transplant and Artificial Insemination Recipients
2. Adenovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  d. Adeno-Associated Viruses(AAV)
3. Aeromonas
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
5. Arboviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
6. Babesiosis
  a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
8. Blastocystis Hominis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
9. Brucella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
10. Campylobacter
  a. Background
  b. Diagnostic Tests
    Identification from Culture
  c. Vaccines and Drugs
11. Candida
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
12. Chagas Disease
  a. Background
13. Chancroid
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
14. Chlamydia
  a. Background
    Chlamydia Psittaci
    Chlamydia Pneumoniae
    Chlamydia Trachomatis
  b. Diagnostic Tests
  c. Vaccines and Drugs
15. Clostridium Difficile
  a. Background
    Pediatric Infections
    Epidemiology
  b. Diagnostic Tests
    Counterimmunoelectrophoresis
    Fluorescent-Antibody Assays
    Poloymerase Chain Reactions
  c. Drugs and Vaccines
16. Coronaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
17. Coxsackieviruses
  a. Background
    Herpangina
    Hand-foot-and-mouth syndrome
    Hepidemic Conjuctivitis
    Pharingitis
    Epidemic Pleurodynia
    Myodarditis,Pericarditis
    Overwhelming Infection of the Newborn
    Acute Aseptic Meningitis
    Undifferentiated Febrile Illness
    Fever with upper respiratory infection
    Encephalitis
    Asymptomatic Infection
  b. Diagnostic Tests
  c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
  a. Background
    Blood Transmission
  b. Diagnostic Tests
    Major Commercial and Academic Players
      Bayer
      Disease Sciences/Bio Tec Global
      Imperial College of Medicine
      Ortho-Clinical Diagnostics
      Pall
      ProMetic Life Sciences
      Proteome Sciences/Idexx
      Q-One Biotech
      Serono
      U.S. Agricultural Research Service
  c. Vaccines
19. Cryptosporidium Parvum
  a. Background
  b. Diagnostic Tests
    Histologic
    Laboratory Parasitology
    Serodiagnosis
  c. Vaccines and Drugs
20. Cyclospora Cayetanensis
  a. Background
    Asymptomatic Infection
    Diarrhea in Immunocompetent Persons
    Diarrhea in Immunocompromisedersons
  b. Diagnostic Tests
  c. Vaccines and Drugs
21. Cytomegalovirus
  a. Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
  b. Diagnostic Tests
  c. Vaccines and Drugs
22. Ebola Virus
  a. Background
    Epidemiology
    Hemorrhagic Fever
  b. Diagnostic Tests
  c. Vaccines and Drugs
23. E. Coli
  a. Background
    Role of Escherichia Coli in Causing Diarrhea
    EPEC
    ETEC
    EIEC
    EHEC
  b. Diagnostic Tests
  c. Vaccines and Drugs
24. EchoVirus
  a. Background
    Acute Aseptic Miningitisis
    Encephalitis
    Exanthems
    Respiratory Disease
    Myope;ricarditis
    Neonatal Infections
  b. Diagnostic Tests
  c. Vaccines and Drugs
25. Encephalitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
26. Enteroviruses
  a. Background
  b. Diagnostic Tests
    Viral Isolation and Identification
    Antibody Tests
  c. Vaccines and Drugs
27. Epstein-Barr Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
28. Giardia Lamblia
  a. Background
    Life Cycle and Morphology
    Morphology of Trophozoites
    Clinical Disease
  b. Diagnostic Tests
  c. Vaccines and Drugs
29. Gonorrhea
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
30. Granuloma Inguinale
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
31. Hantavirus
  a. Background
    Identification of the Agent
    Transmission
    Other Rodent Hantaviruses
    Distribution
    Hantavirus Diseases
    Epidemiology
    Addendum in Proof-Northeastern Connection
    Previously Unknown Pathogens
    Cases Nationwide
  b. Diagnostic Tests
    An Immunohistochemistry Approach
    Hantavirus Rapid Diagnostic Test
    ELISA Diagnosis of Hantavirus Pulmonary Syndrome
    IgG ELISA
    IgM Capture ELISA
  c. Vaccines and Drugs
32. Helicobacter Pylori
  a. Background
    Pathogenesis
    Role in Peptic Ulcer Disease
    Role in Gastric Cancer
    Nonulcer Dyspepsia
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Specific Therapeutic Regimens
    Who Should Be Treated?
    Participants in Controlled Clinical Trials
    Patients with Refractory Peptic Ulcer
    Patients with Refractory NUD
    Patients in High-Risk Groups for Gastric Cancer
33. Hepatitis
  a. Background
  b. Hepatitis A
  c. Hepatitis B
  d. Hepatitis C
    Classification
    Transmission of Infection
    Occupational Hazards
    Acute Hepatitis
    Diagnosis of Acute Infection
    Chronic Hepatitis
    HCV and Other Chronic Liver Diseases
    Alcoholic Liver Disease
    Hepatitis B Coinfection
    Cirrhosis and Hepatocellular Carcinoma
    Diagnostic Tests
    Possible Indications for HCV RNA Testing
    Conclusions and Future Direction
  e. Hepatitis D
    Historical Perspective
    Epidemiology
    HBV-HDV ""Coinfection"" vs. ""Superinfection""
    Methods of Detecting HDV
    Prevention
  f. Hepatitis E
    Background
    Prevalence of the Disease
    Diagnostic Tests
    Epidemiologic Serosurveys
    Serologic Cross-Reactivity
  g. Hepatitis G
    Vaccines and Drugs
34. Herpes Simplex Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
  a. Background
    HIV-6 Infections
  b. Diagnostic Tests
  c. Vaccines and Drugs
36. Influenza Viruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
37. Legionella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
38. Lyme Disease
  a. Background
    Clinical Description
    Clinical Case Definition
    Laboratory Criteria for Diagnosis
    Case Classification
  b. Diagnostic Tests
  c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
40. Malaria
  a. Background
  b. Diagnostic Tests
    Potential Diagnositic Problems with Positive Patients from Non-endemic Areas
      Patient
      Laboratory
      Physician
  c. Vaccines and Drugs
41. Measles (Rubeola)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
42. Meningitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Development of Polysaccharide Vaccines
    Quadrivalent Vaccine Development
    Meningococcal A.C.Y. & W-135 Vaccines
    Efficacy of Group C Vaccine
    Efficacy of Group A Vaccine
    Combinations of Group A and C Vaccines
    Group B Efficacy Trials
    Future Direction
43. Microsporidium
  a. Background
    Prevalence and Geographic Distribution
    Sources of Human Infection and Transmission
  b. Diagnostic Tests
    Light Microscopic Examination of Stool Specimens By Chromotrope Staining
    Stool Concentration Methods
    Chemofluorescent Agents
    Giemsa Staining of Stool Specimens
    Cytologic Diagnosis
    Histologic Examination
    Electron Microscopy
    Examination of Bodily Fluids
    Examination of Tissue Sections
    Immunofluorescence Detection Procedures
    Serology
    Cell Culture
    Approach to Diagnosis
    Evaluation of Patients with Presumptive Intestinal Microsporidiosis
    Evaluation of Patients with Presumptive Ocular Microsporidiosis
  c. Vaccines and Drugs
44. Mononucleosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
45. Mumps
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Efficacy of Vaccination
    Future Issues
46. Mycoplasma
  a. Background
    Ureaplasma Urealyticum & Mycoplasma Hominis
  b. Diagnostic Tests
  c. Vaccines and Drugs
47. Papillomaviruses
  a. Background
    HPV in Cancer
    Cervical Neoplasm
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Prevention
48. Parvovirus B19
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
49. Pneumonia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
50. Polyomaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
  a. Background
    Virulence Factors
  b. Diagnostic Tests
  c. Vaccines and Drugs
52. Rabies
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
54. RhinoViruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
56. Rubella(MEASLES)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Developing Countries
    Elimination and Eradication of Measles
    New Developments
57. Salmonellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
58. Septicemia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
59. Shigellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
60. Staphylococcus Aureus
  a. Background
    The Genus Taphylococcus
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Prevention
61. Streptococci
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Group A Streptococci
    Group B Streptococci
62. Syphilis
  a. Background
  b. Diagnostic Tests
    Biopsy
    Rabbit Infectivity Testing
    Other Diagnostic Modalities
  c. Vaccines and Drugs
    Syphilis and HIV Infection
    Syphilis As a Cofactor for HIV Transmission
    Basic Science Issues
63. Toxoplasmosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
64. Trichomonas Vaginalis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
65. Tuberculosis
  a. Background
  b. Diagnostic Tests
    Microscopic Characteristics
    Cultural Characteristics
    Detection of Antibodies
    Skin Tests
    MDRTB
  c. Vaccines and Drugs
66. Vibrio
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
67. West Nile Virus
  a. Background
      Clinical Syndromes
  b. Diagnostic Tests
  c. Vaccines and Drugs
68. Yersina
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs

B. INSTRUMENTATION REVIEW AND MARKET NEEDS

    Abbott AxSYM
    Abbott IMx/IMx Select
    Anagen AN2000/AuraFlex
    Beckman Coulter Access
    BioChem Pharma/SR1
    BioMerieux/Vitek Vidas
    Biotrol System 7000
    Chiron ACS: Centaur
    Chiron ACS: 180
    J&J Diagnostics/Amersham Amerlite
    J&J Diagnostics Vitros ECi
    Olympus PK310
    Roche Cobas Core
    Roche Elecsys 1010/2010
    Roche ES 22
    Roche ES 33
    Roche ES 300/300AL
    Siemens ELISA Processor II/III
    Siemens Immuno 1
    Siemens/Opus/Plus/Magnum
    Siemens Stratus
    Tosoh AIA-1200/1200DX/NexIA/600
    Wallac/Pharmacia Delfia

C. EMERGING DIAGNOSTIC TECHNOLOGIES

1. DNA Probes
  a. Technology Overview
  b. Amplification Methods
    Polymerase Chain Reaction
      Robotics
      Temperature Cyclers
      PCR Variations
    Immuno-PCR
    QC-PCR
    DAP-PCR
    Ligase Chain Reaction
    Branched DNA
    Q-Beta Replicase
    Nucleic-Acid Sequence-Based
    Strand Displacement Activation
    Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
  a. Technological Principle
  b. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    Dot Immunobinding Assays
    Capillary Immunoassays
    Particle-Membrane Capture Immunoassays
    Enzyme Amplification
  c. Fluorescent Immunoassays
    Fluorescence Polarization
    Time-Resolved Pulse Fluorescence
  d. Luminescence
    Chemiluminescence
    Bioluminescence
  e. Latex Agglutination
  f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other

D. PERSONAL TESTING

E. WORLDWIDE BUSINESS ENVIRONMENT

F. WORLDWIDE MARKET STRUCTURE

G. WORLDWIDE MARKET SIZE AND GROWTH


U.K.   A. Executive Summary
  B. Business Environment
  C. Market Structure
  D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
  A. Instrumentation
  B. Reagent Kits and Test Systems/Panels
  C. Computers, Software and Automation
  D. Auxiliary Products
Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies
  A. Internal Development
  B. Collaborative Arrangements
  C. University Contracts
  D. Distribution Strategies for Decentralized
Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation
Potential Market Entry Barriers and Risks
  A. Market Maturity
  B. Cost Containment
  C. Competition
  D. Technological Edge and Limitations
  E. Patent Protection
  F. Regulatory Constraints
  G. Decentralized Testing Market Challenges
Competitive Assessments
      Abbott
      Affymetrix
      Beckman Coulter
      Becton Dickinson
      bioMerieux
      Bio-Rad
      Cepheid
      Diamedix
      DiaSorin
      Eiken Chemical
      Enzo Biochem
      Fujirebio
      Gen-Probe
      Hologic
      ID Biomedical
      J&J Diagnostics
      Kreatech
      Life Technology
      Lonza
      Nanogen
      Novartis Diagnostics
      Qiagen
      Roche
      Scienion
      Sequenom
      SeraCare
      Siemens
      Takara Bio
      Thermo Fisher
      Wallac
      Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories Performing Microbiology Tests by Country
Worldwide All Market Segments Total Microbiology Test Volume Forecast by Country
Worldwide All Market Segments Total Microbiology Diagnostics Market Forecast by Country
Infectious Disease Tests Major Issues and Market Potential For Personal Testing
U.K. Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Laboratories Performing Infectious Disease Tests by Market Segment
U.K. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
U.K. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
U.K. All Market Segments Infectious Disease Test Volume Forecast
U.K. Hospital Laboratories Infectious Disease Test Volume Forecast
U.K. Blood Banks Infectious Disease Test Volume Forecast
U.K. Public Health Laboratories Infectious Disease Test Volume Forecast
U.K. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
U.K. All Market Segments Infectious Disease Diagnostics Market Forecast
U.K. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
U.K. Blood Banks Infectious Disease Diagnostics Market Forecast
U.K. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
U.K. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
U.K. HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. HTLV-I/II Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. AIDS Testing Market Diagnostics Sales by Major Supplier
U.K. Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.K. Candida Testing Market Diagnostics Sales by Major Supplier
U.K. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.K. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.K. Influenza Testing Market Diagnostics Sales by Major Supplier
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.K. RSV Testing Market Diagnostics Sales by Major Supplier
U.K. Rubella Testing Market Diagnostics Sales by Major Supplier
U.K. Septicemia Testing Market Diagnostics Sales by Major Supplier
U.K. Shigella Testing Market Diagnostics Sales by Major Supplier
U.K. Streptococci Testing Market Diagnostics Sales by Major Supplier
U.K. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.K. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.K. Infectious Disease Diagnostic Testing Instrumentation
Major Systems Estimated Placements and Installed Base
Skip to top


Future German Microbiology Testing Market Outlook US$ 5,015.00 Feb, 2012 · 983 pages
Future Italian Microbiology Testing Market Outlook US$ 5,015.00 Feb, 2012 · 970 pages
Future Japanese Microbiology Testing Market Outlook US$ 6,630.00 Feb, 2012 · 976 pages
Future Spanish Microbiology Testing Market Outlook US$ 5,015.00 Feb, 2012 · 960 pages
Future US Microbiology Testing Market Outlook US$ 7,990.00 Feb, 2012 · 1037 pages

Ask Your Question

Future UK Microbiology Testing Market Outlook
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: